Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 160

1.

Managing dyslipidaemia in type 2 diabetes mellitus.

Szalat A, Durst R, Leitersdorf E.

Best Pract Res Clin Endocrinol Metab. 2016 Jun;30(3):431-44. doi: 10.1016/j.beem.2016.05.004. Epub 2016 May 28. Review.

PMID:
27432076
2.

Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.

Albers JJ, Slee A, Fleg JL, O'Brien KD, Marcovina SM.

Atherosclerosis. 2016 Jun 11. pii: S0021-9150(16)30264-7. doi: 10.1016/j.atherosclerosis.2016.06.019. [Epub ahead of print]

PMID:
27320173
3.

Statin combination therapy and cardiovascular risk reduction.

Toth PP, Farnier M, Tomassini JE, Foody JM, Tershakovec AM.

Future Cardiol. 2016 May;12(3):289-315. doi: 10.2217/fca-2015-0011. Epub 2016 Apr 15.

PMID:
27079178
4.

Familial Hypercholesterolemia.

Bouhairie VE, Goldberg AC.

Endocrinol Metab Clin North Am. 2016 Mar;45(1):1-16. doi: 10.1016/j.ecl.2015.09.001. Review.

PMID:
26892994
5.

The Severe Hypercholesterolemia Phenotype: Genes and Beyond.

Pendyal A, Fazio S.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Nov 16.

6.

LDL cholesterol, statins and PCSK 9 inhibitors.

Gupta S.

Indian Heart J. 2015 Sep-Oct;67(5):419-24. doi: 10.1016/j.ihj.2015.05.020. Epub 2015 Aug 5. Review.

7.

Nonstatin therapies for management of dyslipidemia: a review.

Sando KR, Knight M.

Clin Ther. 2015 Oct 1;37(10):2153-79. doi: 10.1016/j.clinthera.2015.09.001. Epub 2015 Sep 26. Review.

PMID:
26412799
8.

Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.

Hegele RA, Gidding SS, Ginsberg HN, McPherson R, Raal FJ, Rader DJ, Robinson JG, Welty FK.

Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2269-80. doi: 10.1161/ATVBAHA.115.306442. Epub 2015 Sep 16. Review.

PMID:
26376908
9.

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia.

Ito MK, Watts GF.

Drugs. 2015 Oct;75(15):1715-24. doi: 10.1007/s40265-015-0466-y. Review.

10.

Antilipidemic Drug Therapy Today and in the Future.

Kramer W.

Handb Exp Pharmacol. 2016;233:373-435. doi: 10.1007/164_2015_15. Review.

PMID:
26330256
11.

Diabetes and Dyslipidemia.

Feingold KR, Grunfeld C.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Jun 10.

12.

Risk Assessment and Guidelines for the Management of High Blood Cholesterol.

Grundy S.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Jun 12.

13.

Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Kones R, Rumana U.

Drugs. 2015 Jul;75(11):1201-28. doi: 10.1007/s40265-015-0429-3. Review.

PMID:
26169307
14.

Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials.

Ip CK, Jin DM, Gao JJ, Meng Z, Meng J, Tan Z, Wang JF, Geng DF.

Int J Cardiol. 2015 Jul 15;191:138-48. doi: 10.1016/j.ijcard.2015.04.228. Epub 2015 Apr 30. Review.

PMID:
25965621
15.

Familial hypercholesterolemia.

Bouhairie VE, Goldberg AC.

Cardiol Clin. 2015 May;33(2):169-79. doi: 10.1016/j.ccl.2015.01.001. Review.

16.

Update of Clinical Trials of Anti-PCSK9 Antibodies.

Wu NQ, Li S, Li JJ.

Cardiovasc Drugs Ther. 2015 Apr;29(2):159-69. doi: 10.1007/s10557-015-6582-9. Review.

PMID:
25916406
17.

Role of Glucose and Lipids in the Cardiovascular Disease of Patients with Diabetes.

Feingold KR, Grunfeld C.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Feb 15.

18.

Role for combination therapy in diabetic dyslipidemia.

Warraich HJ, Wong ND, Rana JS.

Curr Cardiol Rep. 2015 May;17(5):32. doi: 10.1007/s11886-015-0589-5. Review.

PMID:
25894802
19.

Improving the odds: ezetimibe and cardiovascular disease.

Viljoen A, Wierzbicki AS.

Int J Clin Pract. 2015 Apr;69(4):390-5. doi: 10.1111/ijcp.12613.

PMID:
25816908
20.

Treatment of dyslipidemia in HIV.

Sekhar RV.

Curr Atheroscler Rep. 2015 Apr;17(4):493. doi: 10.1007/s11883-015-0493-x. Review.

PMID:
25702057
Items per page

Supplemental Content

Loading ...
Write to the Help Desk